Parvovirus B19 infection as trigger of graft vs. host disease.
Behre
Gerhard
G
Department of Internal Medicine IV, Oncology and Hematology, University Hospital Halle (Saale), Halle (Saale), Germany.
Christopeit
Maximilian
M
D000208:Acute Disease; D000328:Adult; D000956:Antigens, Viral / Q000276:immunology; D003092:Colitis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D003429:Cross Reactions / Q000276:immunology; D016731:Erythema Infectiosum / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D005076:Exanthema / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000150:complications* / Q000276:immunology / Q000628:therapy; D008297:Male; D016732:Parvovirus B19, Human / Q000276:immunology; D036102:Peripheral Blood Stem Cell Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous
D000956:Antigens, Viral